Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin improves live birth rates in POSEIDON group 3 and 4 expected poor responders

References

• Ovarian Stimulation TEGGO, Bosch E, Broer S, et al. ESHRE Guideline: ovarian Stimulation for IVF/ICSI. Hum Reprod Open. 2020;2020(2):hoaa009. Published 2020 May 1.
   PubMedGoogle Scholar
• Humaidan P, Alviggi C, Fischer R, et al. The novel POSEIDON stratification of ‘low prognosis patients in assisted reproductive technology’ and its proposed marker of successful outcome. F1000Res. 2016;5:2911. Published 2016 Dec 23.
   PubMedGoogle Scholar
• Haas J, Zilberberg E, Nahum R, et al. Does double trigger (GnRH-agonist + hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study. Gynecol Endocrinol. 2019;35(7):628–630.
   PubMed Web of Science ®Google Scholar
• Diminished Ovarian Reserve and Assisted Reproductive Technologies Current Research and Clinical Management, Orhan Bukulmez, Springer International Publishing, 2020.
   Google Scholar
• Orvieto R. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation. J Ovarian Res. 2015;8:69.
   PubMed Web of Science ®Google Scholar
• Haas J, Bassil R, Samara N, et al. GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study. Hum Reprod. 2020;35(7):1648–1654.
   PubMed Web of Science ®Google Scholar
• Haas J, Ophir L, Barzilay E, et al. Standard human chorionic gonadotropin versus double trigger for final oocyte maturation results in different granulosa cells gene expressions: a pilot study. Fertil Steril. 2016;106(3):653–659.e1.
   PubMed Web of Science ®Google Scholar
• Zelinski-Wooten MB, Hutchison JS, Hess DL, et al. A bolus of recombinant human follicle stimulating hormone at midcycle induces periovulatory events following multiple follicular development in macaques. Hum Reprod. 1998;13(3):554–560.
   PubMed Web of Science ®Google Scholar
• Humaidan P, Kol S, Papanikolaou EG, Copenhagen GnRH Agonist Triggering Workshop Group. GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update. 2011;17(4):510–524.
   PubMed Web of Science ®Google Scholar
• Shapiro BS, Daneshmand ST, Garner FC, et al. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Fertil Steril. 2008;90(1):231–233.
   PubMed Web of Science ®Google Scholar
• Ding N, Liu X, Jian Q, et al. Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: a systematic review and Meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2017;218:92–98.
   PubMed Web of Science ®Google Scholar
• Lin MH, Wu FS, Hwu YM, et al. Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve. Reprod Biol Endocrinol. 2019;17(1):7. Published 2019 Jan 4.
   PubMedGoogle Scholar
• Maged AM, Ragab MA, Shohayeb A, et al. Comparative study between single versus dual trigger for poor responders in GnRH-antagonist ICSI cycles: a randomized controlled study. Int J Gynaecol Obstet. 2021;152(3):395–400.
   PubMed Web of Science ®Google Scholar
• Chern CU, Li JY, Tsui KH, et al. Dual-trigger improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve: a retrospective cohort study. PLoS One. 2020;15(7):e0235707. Published 2020 Jul 6.
   PubMed Web of Science ®Google Scholar
• Eser A, Devranoğlu B, Bostancı Ergen E, et al. Bostancı ergen E, yayla abide Ç. Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders. J Turk Ger Gynecol Assoc. 2018;19(2):98–103.
   PubMed Web of Science ®Google Scholar
• Eftekhar M, Mohammadi B, Khani P, et al. Dual stimulation in unexpected poor responder POSEIDON classification group 1, Sub-group 2a: a cross-sectional study. Int J Reprod Biomed. 2020;18(6):465–470. Published 2020 Jun 30.
   PubMed Web of Science ®Google Scholar
• Zegers-Hochschild F, Adamson GD, Dyer S, et al. The ınternational glossary on ınfertility and fertility care, 2017. Fertil Steril. 2017;108(3):393–406.
   PubMed Web of Science ®Google Scholar
• Racowsky C, Vernon M, Mayer J, et al. Standardization of grading embryo morphology. J Assist Reprod Genet. 2010;27(8):437–439.
   PubMed Web of Science ®Google Scholar
• Griffin D, Feinn R, Engmann L, et al. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates. Fertil Steril. 2014;102(2):405–409.
   PubMed Web of Science ®Google Scholar
• Kim CH, Ahn JW, You RM, et al. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization. J Reprod Med. 2014;59(1-2):63–68.
   PubMed Web of Science ®Google Scholar
• Popovici RM, Kao LC, Giudice LC. Discovery of new inducible genes in in vitro decidualized human endometrial stromal cells using microarray technology. Endocrinology. 2000;141(9):3510–3513.
   PubMed Web of Science ®Google Scholar
• Liu J, Maccalman CD, Wang YL, et al. Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways [published correction appears. Mol Endocrinol. 2009;23(7):1014–1021.
   PubMedGoogle Scholar
• Rackow BW, Kliman HJ, Taylor HS. GnRH antagonists may affect endometrial receptivity. Fertil Steril. 2008;89(5):1234–1239.
   PubMed Web of Science ®Google Scholar
• Guo S, Li Z, Yan L, et al. GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity. Drug Des Devel Ther. 2018;12:1621–1631. Published 2018 Jun 7.
   PubMed Web of Science ®Google Scholar
• Tesarik J, Hazout A, Mendoza C. Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Hum Reprod. 2004;19(5):1176–1180.
   PubMed Web of Science ®Google Scholar
• Raga F, Casañ EM, Kruessel J, et al. The role of gonadotropin-releasing hormone in murine preimplantation embryonic development. Endocrinology. 1999;140(8):3705–3712.
   PubMed Web of Science ®Google Scholar
• Zhou X, Guo P, Chen X, et al. Comparison of dual trigger with combination GnRH agonist and hCG versus hCG alone trigger of oocyte maturation for normal ovarian responders. Int J Gynaecol Obstet. 2018;141(3):327–331.
   PubMed Web of Science ®Google Scholar
• Seval MM, Özmen B, Atabekoğlu C, et al. Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles. J Obstet Gynaecol Res. 2016;42(9):1146–1151.
   PubMed Web of Science ®Google Scholar
• Lin MH, Wu FS, Lee RK, et al. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Fertil Steril. 2013;100(5):1296–1302.
   PubMed Web of Science ®Google Scholar
• Griffin D, Benadiva C, Kummer N, et al. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Fertil Steril. 2012;97(6):1316–1320.
   PubMed Web of Science ®Google Scholar